The ISO 27001:2022 standard, an internationally recognised standard for information security management systems (ISMS), was awarded to GENIAL this July.

The certification follows a successful audit by an accredited certification body and confirms that GENIAL has implemented processes and controls for managing information security risks in accordance with the requirements of ISO/IEC 27001:2022.

For a company working with biomedical and sensitive research data, robust information security practices are fundamental.

The certification therefore represents an important milestone in GENIAL’s continued development of secure and reliable solutions for life sciences research.